相关实验视频
Updated: Jun 14, 2025

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
1.9K
生态和进化动态来设计和改进卵巢癌治疗方法
Grace Y Q Han1, Monica Alexander2, Julia Gattozzi3
1Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
Clinical and translational medicine
|August 30, 2024
概括
卵巢癌的治疗由于药物耐药性而失败. 需要新的生态进化策略来管理癌细胞的可塑性,并改善转移性卵巢癌患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 进化生物学 进化生物学
- 癌症研究 癌症研究
背景情况:
- 卵巢癌的特点是复杂,异质的细胞群和微环境.
- 目前的治疗方法,如PARP抑制剂,向疗法和免疫疗法,由于获得药物耐药性而面临局限性.
- 转移性卵巢癌的高死亡率强调了需要新的治疗策略.
研究的目的:
- 审查当前的卵巢癌治疗选择和挑战.
- 讨论瘤进化原理及其对治疗耐药性的影响.
- 为管理卵巢癌和药物耐药性提出进化知情策略.
主要方法:
- 审查关于卵巢癌治疗,瘤微环境和进化动态的现有文献.
- 分析导致癌细胞耐药性的因素,包括异质性和可塑性.
- 开发生态进化处理设计的概念框架.
主要成果:
- 瘤的功能是复杂的生态系统,癌症和非癌症细胞相互作用和进化.
- 传统疗法往往无法解释瘤异质性和细胞可塑性,从而导致耐药性.
- 了解进化动态对于克服卵巢癌治疗耐药性至关重要.
结论:
- 成功管理卵巢癌需要整合生态和进化原则.
- 生态进化设计的疗法应考虑癌细胞可塑性和患者特异性因素.
- 纵向数据集成是改善治疗设计和管理耐药性的关键.
相关概念视频
Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

